Otsuka Holdings Co., Ltd. (OTSKF) Stock Price & Analysis
Otsuka Holdings Co., Ltd. (OTSKF) closed at USD 72 on Wednesday, October 21, 2026, down 1.58% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 73.16; the Oct 21, 2026 session ranged USD 72–72 on volume of 41 shares. Market capitalization is $37.77B, with a 52-week range of USD 54.26–79 (PNK). Source: Nexqual, retrieved October 23, 2026 at 16:41 UTC.
Also available as compact Markdown for AI agents: nexqual.com/OTSKF.md
Key facts (OTSKF)
- Analysts: None.
- Total return with dividends: 1Y +28.5% vs S&P 500 +14.6%; 5Y +88.7% vs S&P 500 +77.3%.
- Next earnings: 2026-10-30, EPS estimate USD —, revenue estimate $704B.
Analysts (OTSKF)
Consensus None.
Total return (dividends reinvested) (OTSKF)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +28.5% | +88.7% |
| S&P 500 (SPY) | +14.6% | +77.3% |
| Per year | +28.6% | +13.6% |
| Volatility (annualized) | 26.7% | 31.4% |
| Max drawdown | -11.4% (Apr 2026→Jun 2026) | -29.3% (Nov 2024→Jul 2025) |
OTSKF analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | — | — | — | $703.79B | — |
| Next quarter (ends Dec 2026) | — | — | — | $713.00B | — |
| Current fiscal year (ends Dec 2026) | — | — | — | $2.75T | — |
| Next fiscal year (ends Dec 2027) | — | — | — | $2.82T | — |
Key Statistics (as of October 23, 2026 at 16:41 UTC)
| Price | USD 72 |
|---|---|
| Change | ▼ 1.58% (down) |
| Previous Close | USD 73.16 |
| Open | USD 72 |
| Day Range | USD 72 – 72 |
| 52-Week Range | USD 54.26 – 79 |
| Volume | 41 shares |
| Market Cap | $37.77B |
| Exchange | PNK |
Technical Analysis (OTSKF)
Nexqual's technical model rates OTSKF "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 16:41 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 74.9) |
| MACD | -0.3 (negative) |
Analyst Ratings (OTSKF)
Wall Street analysts rate OTSKF "None", per Nexqual as of October 23, 2026 at 16:41 UTC.
| Consensus Rating | None |
|---|
Earnings (OTSKF)
| Next Earnings Date | 2026-10-30 |
|---|---|
| Revenue Estimate | $703.79B |
Source: Nexqual, October 23, 2026 at 16:41 UTC.
Financials & Fundamentals (OTSKF)
| Total Revenue | $2.62T |
|---|---|
| Revenue Growth (latest quarter, YoY) | +17.40% |
| Gross Margin | +71.78% |
| Operating Margin | +20.54% |
| Profit Margin | +15.46% |
| ROE | +13.42% |
| Debt / Equity | 0.06 |
| Current Ratio | 2.21 |
| Total Cash | $469.55B |
| Total Debt | $194.20B |
Source: Nexqual, October 23, 2026 at 16:41 UTC.
Financial Health Score (OTSKF)
Nexqual rates Otsuka Holdings Co., Ltd.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 16:41 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 72%, operating 21% (last 12 months) |
| Balance Sheet | Strong — JPY 469.5B cash vs JPY 194.2B debt, net cash position |
| Cash Flow | Solid — Operating cash flow JPY 408.0B (TTM) |
| Efficiency | Mixed — ROE 13%, ROA 7.0% |
Ownership (OTSKF)
| Insider Ownership | +4.89% |
|---|---|
| Institutional Ownership | +44.34% |
| Shares Outstanding | 524.61M |
| Float | 445.18M |
Source: Nexqual, October 23, 2026 at 16:41 UTC.
Leadership (OTSKF)
Otsuka Holdings Co., Ltd. is led by Makoto Inoue, President, CEO & Representative Director, per Nexqual as of October 23, 2026 at 16:41 UTC.
| President, CEO & Representative Director | Makoto Inoue |
|---|---|
| CFO & Executive Director | Yuko Makino |
| Executive Director | Noriko Tojo |
| Executive Deputy President & Representative Director | Yoshiro Matsuo |
| Executive Director | Masayuki Kobayashi |
Major Backers & Investors (OTSKF)
Notable institutional backers of Otsuka Holdings Co., Ltd. include Fidelity, J.P. Morgan Exchange-Traded Fund Trust-JPMorgan BetaBuilders Japan ETF, Aristotle Capital Management, LLC, according to Nexqual as of October 23, 2026 at 16:41 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.3% |
| J.P. Morgan Exchange-Traded Fund Trust-JPMorgan BetaBuilders Japan ETF | 0.29% |
| Aristotle Capital Management, LLC | 0.21% |
| Charles Schwab | 0.18% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 3.19% |
| BlackRock | 1.2% |
Source: Nexqual, October 23, 2026 at 16:41 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIIB | Biogen Inc. | USD 250.61 | ▼ 1.27% |
| SNY | Sanofi | USD 41.51 | ▼ 1.07% |
| GSK | GSK plc | USD 50.66 | ▼ 1.07% |
| BMY | Bristol-Myers Squibb Company | USD 61.82 | ▼ 1.87% |
| PFE | Pfizer, Inc. | USD 30.08 | ▼ 1.12% |
| NVO | Novo Nordisk A/S | USD 39.05 | ▼ 0.96% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:41 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt